메뉴 건너뛰기




Volumn 35, Issue 4, 2010, Pages 387-391

Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia

Author keywords

Escherichia coli; Fluoroquinolones; Geographic distribution; QRDR

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; PAZUFLOXACIN; PROTEIN PARC; PROTEIN PARE; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

EID: 76749107390     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.12.005     Document Type: Article
Times cited : (23)

References (15)
  • 1
    • 23244465296 scopus 로고    scopus 로고
    • Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa
    • Ray G.T., Baxter R., and DeLorenze G.N. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa. Clin Infect Dis 41 (2005) 441-449
    • (2005) Clin Infect Dis , vol.41 , pp. 441-449
    • Ray, G.T.1    Baxter, R.2    DeLorenze, G.N.3
  • 2
    • 33748885240 scopus 로고    scopus 로고
    • The worldwide emergence of plasmid-mediated quinolone resistance
    • Robicsek A., Jacoby G.A., and Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6 (2006) 629-640
    • (2006) Lancet Infect Dis , vol.6 , pp. 629-640
    • Robicsek, A.1    Jacoby, G.A.2    Hooper, D.C.3
  • 3
    • 35348894748 scopus 로고    scopus 로고
    • New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate
    • Yamane K., Wachino J., Suzuki S., Kimura K., Shibata N., Kato H., et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51 (2007) 3354-3360
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3354-3360
    • Yamane, K.1    Wachino, J.2    Suzuki, S.3    Kimura, K.4    Shibata, N.5    Kato, H.6
  • 4
    • 21844477302 scopus 로고    scopus 로고
    • Mechanisms of resistance to quinolones
    • Jacoby G.A. Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl. 2 (2005) S120-S126
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 2
    • Jacoby, G.A.1
  • 5
    • 17644405067 scopus 로고    scopus 로고
    • Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments
    • Hopkins K.L., Davies R.H., and Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25 (2005) 358-373
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 358-373
    • Hopkins, K.L.1    Davies, R.H.2    Threlfall, E.J.3
  • 6
    • 0141924871 scopus 로고    scopus 로고
    • Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections
    • Komp Lindgren P., Karlsson A., and Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 47 (2003) 3222-3232
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 3222-3232
    • Komp Lindgren, P.1    Karlsson, A.2    Hughes, D.3
  • 7
    • 34548075831 scopus 로고    scopus 로고
    • Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates
    • Sorlozano A., Gutierrez J., Jimenez A., de Dios Luna J., and Martinez J.L. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates. J Clin Microbiol 45 (2007) 2740-2742
    • (2007) J Clin Microbiol , vol.45 , pp. 2740-2742
    • Sorlozano, A.1    Gutierrez, J.2    Jimenez, A.3    de Dios Luna, J.4    Martinez, J.L.5
  • 8
    • 19544393748 scopus 로고    scopus 로고
    • Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections
    • Komp Lindgren P., Marcusson L.L., Sandvang D., Frimodt-Moller N., and Hughes D. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 49 (2005) 2343-2351
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2343-2351
    • Komp Lindgren, P.1    Marcusson, L.L.2    Sandvang, D.3    Frimodt-Moller, N.4    Hughes, D.5
  • 10
    • 4844226727 scopus 로고    scopus 로고
    • Genomic subtraction for the identification of putative new virulence factors of an avian pathogenic Escherichia coli strain of O2 serogroup
    • Schouler C., Koffmann F., Amory C., Leroy-Setrin S., and Moulin-Schouleur M. Genomic subtraction for the identification of putative new virulence factors of an avian pathogenic Escherichia coli strain of O2 serogroup. Microbiology 150 (2004) 2973-2984
    • (2004) Microbiology , vol.150 , pp. 2973-2984
    • Schouler, C.1    Koffmann, F.2    Amory, C.3    Leroy-Setrin, S.4    Moulin-Schouleur, M.5
  • 11
    • 34547828223 scopus 로고    scopus 로고
    • Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates
    • Cattoir V., Poirel L., Rotimi V., Soussy C.J., and Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60 (2007) 394-397
    • (2007) J Antimicrob Chemother , vol.60 , pp. 394-397
    • Cattoir, V.1    Poirel, L.2    Rotimi, V.3    Soussy, C.J.4    Nordmann, P.5
  • 12
    • 39049194832 scopus 로고    scopus 로고
    • In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid
    • Cattoir V., Lesprit P., Lascols C., Denamur E., Legrand P., Soussy C.J., et al. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid. J Antimicrob Chemother 58 (2006) 1054-1057
    • (2006) J Antimicrob Chemother , vol.58 , pp. 1054-1057
    • Cattoir, V.1    Lesprit, P.2    Lascols, C.3    Denamur, E.4    Legrand, P.5    Soussy, C.J.6
  • 13
    • 59649124028 scopus 로고    scopus 로고
    • High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals
    • Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., et al. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob Agents Chemother 53 (2009) 519-524
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 519-524
    • Ma, J.1    Zeng, Z.2    Chen, Z.3    Xu, X.4    Wang, X.5    Deng, Y.6
  • 14
    • 0345827436 scopus 로고    scopus 로고
    • SOS response promotes horizontal dissemination of antibiotic resistance genes
    • Beaber J.W., Hochhut B., and Waldor M.K. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427 (2004) 72-74
    • (2004) Nature , vol.427 , pp. 72-74
    • Beaber, J.W.1    Hochhut, B.2    Waldor, M.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.